Clinical Trial Update: Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 trial comparing subconjunctival triamcinolone injection to intravitreal dexamethasone implant for inflammatory macular edema; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Macular Edema

Drugs mentioned

• Triamcinolone (triamcinolone)
• dexamethasone implant

Snippet

Sponsor: Nantes University Hospital | Conditions: Inflammatory Macular Edema | Phase 3 | Status: COMPLETED